Zhi-Song He
Overview
Explore the profile of Zhi-Song He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
406
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu J, Pan X, Xie J, Chen Y, Fan Y, Yu W, et al.
Int J Urol
. 2024 Jan;
31(5):536-543.
PMID: 38291596
Objectives: To explore the relationship between Fuhrman grade of renal cell carcinoma (RCC) and the DDD score. Methods: We reviewed the records of 527 nonmetastatic RCC patients. Demographic, clinical, and...
2.
Qi X, Zhang Z, Gao X, Qin S, Bai Y, Yu W, et al.
Transl Androl Urol
. 2023 Feb;
12(1):128-138.
PMID: 36760876
Background: The amount of treatment-related neuroendocrine prostate cancer (t-NEPC) increases after hormonal therapy, especially novel androgen receptor pathway inhibitors (ARPIs). T-NEPC is considered a hormone refractory [androgen receptor (AR)-negative] subtype...
3.
Xu C, He Z, Lei W, Zhu J, Zhao D, Kong J, et al.
Clin Respir J
. 2023 Feb;
17(4):270-276.
PMID: 36759335
Background: Understanding of the early immune response in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infections is limited. Methods: Ninety-eight patients with coronavirus disease 2019 (COVID-19) breakthrough infections were...
4.
Peng Y, Xiong L, Zhou Z, Ning K, Li Z, Wu Z, et al.
J Immunother Cancer
. 2022 Feb;
10(2).
PMID: 35121646
Purpose: Recurrent renal cell carcinoma(reRCC) is associated with poor prognosis and the underlying mechanism is not yet clear. A comprehensive understanding of tumor microenvironment (TME) of reRCC may aid in...
5.
Bai G, Mi Y, Song Y, Hao J, He Z, Jin J
World J Clin Cases
. 2021 Jul;
9(19):5339-5344.
PMID: 34307587
Background: Secondary jejunal tumor from renal cell carcinoma (RCC) is extremely rare in clinical practice and is easily missed and misdiagnosed because of the low incidence and atypical symptoms. Case...
6.
Wu Q, Liu L, Jiang X, Hu Y, Liang Q, He Z, et al.
Trials
. 2020 Jul;
21(1):602.
PMID: 32611442
Background: At present, China has more than 11 million patients with stable coronary heart disease and this is becoming a major public health problem. The pathological changes of coronary heart...
7.
Ma B, Yao L, Fan Y, Wang Y, Meng Y, Zhang Q, et al.
Cancer Manag Res
. 2019 Jun;
11:4143-4151.
PMID: 31190986
Radical surgery is the preferred method for local high-risk and limited progressive prostate cancer in the routine clinical setting. However, current guidelines do not recommend neoadjuvant hormone therapy (NHT). Opinions...
8.
Jia Z, Gong Y, Zhang C, Bao Z, Li X, Hao H, et al.
Can Urol Assoc J
. 2018 Nov;
13(7):E202-E209.
PMID: 30472983
Introduction: We aimed to compare oncological outcomes by surgery type (segmental ureterectomy [SU] vs. radical nephroureterectomy [RNU]) in a large cohort of patients with upper tract urothelial carcinoma (UTUC) of...
9.
Ma B, Yao L, Yu W, Wang Y, Song H, Zhang Z, et al.
Asian J Androl
. 2018 Jul;
20(6):581-586.
PMID: 30027927
Traditional laparoscopic radical prostatectomy is a treatment choice in many developing countries and regions for most patients with localized prostate cancer; however, no system for predicting surgical difficulty and risk...
10.
Peng D, Zhang C, Tang Q, Zhang L, Yang K, Yu X, et al.
BMC Urol
. 2018 Mar;
18(1):20.
PMID: 29544476
Background: To evaluate the prognostic significance of the novel index combining preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in renal cell carcinoma (RCC) patients. Methods: We...